AllSci News
Earendil secures USD 1.5b-plus oncology deal with Genentech for AI-designed bispecific antibodies
Wilmington, Delaware-based Earendil Labs has entered a research collaboration with Genentech to discover and develop multiple bispecific antibody programs...
Arcturus unveils next-generation mRNA platform with 38-fold potency boost for OTC deficiency
San Diego-based Arcturus Therapeutics (Nasdaq: ARCT) reported encouraging interim Phase II data for ARCT-810, its investigational mRNA therapeutic for...
Astellas moves KRAS G12D degrader setidegrasib into Phase III lung cancer trial
Astellas Pharma (TSE: 4503) dosed the first patient in a Phase III trial of setidegrasib, its investigational KRAS G12D-targeted protein degrader, in...
Lilly expands China biotech strategy with USD 3.25b InnoCare discovery collaboration
Beijing-based InnoCare Pharma (HKEX: 09969) has entered a strategic research collaboration and license agreement with Eli Lilly and Company (NYSE: LLY)...
FDA advisory panel backs GRAIL's Galleri multi-cancer early detection test
An FDA advisory committee has voted in favor of approving Galleri, a multi-cancer early detection (MCED) test developed by Sunnyvale, California-based...
Zymeworks closes out acquisition of Theravance for USD 929m
Vancouver, British Columbia-based Zymeworks Inc. (Nasdaq: ZYME) has completed its acquisition of Theravance Biopharma, adding a commercial-stage respiratory...
Basecamp Research scales AI-designed drug pipeline with USD 140m Series C
London-based Basecamp Research has raised USD 140 million in an oversubscribed Series C round led by S32, with proceeds directed toward training a new...
Immunovant drops IMVT-1402 in cutaneous lupus after proof-of-concept miss
Immunovant (Nasdaq: IMVT) reported that its FcRn inhibitor imeroprubart (IMVT-1402) failed to meet the primary endpoint in a proof-of-concept trial in...
Variant Bio expands Boehringer deal into cardiovascular disease with USD 250m at stake
Seattle-based Variant Bio has expanded its multi-year research collaboration and license agreement with Boehringer Ingelheim into cardiovascular disease,...
Anthropic uses autonomous AI agents to uncover novel bacteriophage enzyme system
Researchers at San Francisco-based Anthropic have used autonomous AI agents to identify a previously uncharacterized enzyme system in bacteriophages,...
Flagship Pioneering secures USD 47 million Pentagon contract for biological threat countermeasures
Flagship Pioneering, a Cambridge, Massachusetts-based life sciences venture creation firm that builds and backs biotechnology platform companies, has...
Enveda secures USD 311m to advance three AI-discovered clinical-stage programs
Boulder, Colorado-based Enveda has raised USD 311 million in a Series E financing led by Catalio Capital Management, with proceeds earmarked to advance...
FDA grants Breakthrough status to Glycomine therapy for rare inherited metabolic disorder
San Carlos, California-based Glycomine, Inc. has received US FDA Breakthrough Therapy Designation (BTD) for GLM101, an investigational liposomal...
Merck KGaA's USD 11.3b Bio-Techne acquisition clears final shareholder approval hurdle
Shareholders of Bio-Techne Corporation (NASDAQ: TECH) voted on September 23, 2026 to approve the definitive merger agreement under which Merck KGaA,...
Caliway reports positive Phase IIb data for CBL-514 in Dercum’s disease
Taiwan-based Caliway Biopharmaceuticals (TWSE: 6919) has reported positive final results from its placebo-controlled Phase IIb trial of CBL-514 in Dercum's...
The AllSci Brief
Free, systematic R&D and deal news. Daily.